Natural History Study - Mitochondrial Disease

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT01532791
Status
Recruiting

Conditions

  • MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier

Eligibility Criteria

Sex
ALL
Age
4 Years - N/A
Healthy Volunteers
Accepted

Study Details

Carriers of the m.3242A\>G mutation often have clinical symptoms which can include migraines, seizures, strokes, hearing loss, balance issues, gastrointestinal issues, and many other symptoms. The investigators would like to learn more about these disorders and have designed a "Natural History Study" to monitor these conditions over time so that physicians and scientists can not only understand the problems that patients have, but work on developing treatments. The focus of the current work is to evaluate known mutation carriers of the m.3243A\>G (mitochondrial DNA) and their maternal relatives (carrier status not a requirement for participation). Paternal relatives will serve as controls. This study involves no treatment.

Key Dates

Start date
Jul 31, 2004
Status verified
Jan 2026
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: mtDNA mutation
    m.3243 A\>G carriers and their maternal relatives Other mutations in the mitochondrial genome may be included
  • Arm: Control
    controls (people not maternally related to mutation carriers) Preference is for married in relatives

Primary Outcome Measure

MRI/MRS [ Time Frame: 2-3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia UniversityNew YorkNew York10032
Kris Engelstad, MS
'-212-305-6834

Find similar trials in New York, NY